Stockreport

Erasca (ERAS) Is Up 10.4% After $225M Follow-On Offering And RAS Pipeline Updates - Has The Bull Case Changed? [Yahoo! Finance]

Erasca, Inc.  (ERAS) 
PDF This fundraising, coupled with encouraging updates on its RAS-focused programs like ERAS-0015 and ERAS-4001, has sharpened investor attention on Erasca's drug developme [Read more]